{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:55:30Z","timestamp":1791654930456,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"S4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["MMW - Fortschritte der Medizin"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s15006-021-9762-5","type":"journal-article","created":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T11:23:53Z","timestamp":1618226633000},"page":"19-26","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Klinische Evidenz zu Probiotika  in der Pr\u00e4vention einer  Antibiotika-assoziierten Diarrh\u00f6","Systematic review: clinical evidence of probiotics in the prevention of antibiotic-associated diarrhoea"],"prefix":"10.1007","volume":"163","author":[{"given":"Martin","family":"Storr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Stengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,29]]},"reference":[{"key":"9762_CR4253","doi-asserted-by":"crossref","unstructured":"McFarland LV. Antibiotic-associated diarrhea: epidemiology, trends and treatment. Future Microbiol 2008; 3(5): 563-578.","DOI":"10.2217\/17460913.3.5.563"},{"key":"9762_CR4257","unstructured":"Stein J. Antibiotikaassoziierte Diarrh\u00f6 und pseudomembran\u00f6se Kolitis. In: Caspary WF, M\u00f6ssner J, Stein J (Hrsg). Therapie gastroenterologischer Krankheiten. Springer, Berlin 2005, S. 169-175."},{"key":"9762_CR4261","unstructured":"More MI, Swidsinski A. Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis - a review. Clin Exp Gastroenterol 2015; 11: 237-255."},{"key":"9762_CR4265","doi-asserted-by":"crossref","unstructured":"Maier L, Pruteanu M, Kuhn M, et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 2018; 555(7698): 623-628.","DOI":"10.1038\/nature25979"},{"key":"9762_CR4269","doi-asserted-by":"crossref","unstructured":"Swidsinski A, Loening-Baucke V, Schulz S, Manowsky J, Verstraelen H, Swidsinski S. Functional anatomy of the colonic bioreactor: Impact of antibiotics and Saccharomyces boulardii on bacterial composition in human fecal cylinders. Syst Appl Microbiol 2016; 39(1): 67-75.","DOI":"10.1016\/j.syapm.2015.11.002"},{"key":"9762_CR4273","doi-asserted-by":"crossref","unstructured":"Clausen MR, Bonnen H, Tvede M, Mortensen PB. Colonic fermentation to short-chain fatty acids is decreased in antibiotic-associated diarrhea. Gastroenterology 1991; 101(6): 1497-504.","DOI":"10.1016\/0016-5085(91)90384-W"},{"key":"9762_CR4277","unstructured":"Guarner F, Sanders ME, Eliakim R, et al. World Gastroenterology Organisation Global Guidelines: Probiotics and prebiotics. 2017."},{"key":"9762_CR4281","doi-asserted-by":"crossref","unstructured":"Guo Q, Goldenberg JZ, Humphrey C, El Dib R, Johnston BC. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev 2019; 4: CD004827.","DOI":"10.1002\/14651858.CD004827.pub5"},{"key":"9762_CR4400","doi-asserted-by":"crossref","unstructured":"Bin Z, Ya-Zheng X, Zhao-Hui D, Bo C, Li-Rong J, Vandenplas Y. The efficacy of Saccharomyces boulardii CNCM I-745 in addition to standard helicobacter pylori eradication treatment in children. Pediatr Gastroenterol Hepatol Nutr 2015; 18(1): 17-22.","DOI":"10.5223\/pghn.2015.18.1.17"},{"key":"9762_CR4404","unstructured":"Casem RAO. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea in children: a randomized controlled trial. PIDSP 2013; 13(2): 70-76."},{"key":"9762_CR4408","doi-asserted-by":"crossref","unstructured":"Erdeve O, Tiras U, Dallar Y. The probiotic effect of Saccharomyces boulardii in a pediatric age group. J Trop Pediatr 2004; 50(4): 234-236.","DOI":"10.1093\/tropej\/50.4.234"},{"key":"9762_CR4412","doi-asserted-by":"crossref","unstructured":"Kotowska M, Albrecht P, Szajewska H. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 2005; 21(5): 583-590.","DOI":"10.1111\/j.1365-2036.2005.02356.x"},{"key":"9762_CR4416","doi-asserted-by":"crossref","unstructured":"Shan LS, Hou P, Wang ZJ, et al. Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections. Benef Microbes 2013; 4(4): 329-334.","DOI":"10.3920\/BM2013.0008"},{"key":"9762_CR4420","unstructured":"Wan CM, Yu H, Liu G, et al. A multicenter randomized controlled study of Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea in infants and young children. Zhonghua Er Ke Za Zhi 2017; 55(5): 349-354."},{"key":"9762_CR4424","unstructured":"Adam M, et al. Controlled double blind clinical trials of Saccharomyces boulardii: Multicentre study involving 25 physicians and 388 cases. Med Chirurg Dig 1976; 5(6): 401-406."},{"key":"9762_CR4428","doi-asserted-by":"crossref","unstructured":"Bravo MV, Bunout D, Leiva L, et al. Effect of probiotic Saccharomyces boulardii on prevention of antibiotic-associated diarrhea in adult outpatients with amoxicillin treatment. Rev Med Chil 2008; 136(8): 981-988.","DOI":"10.4067\/S0034-98872008000800004"},{"key":"9762_CR4432","unstructured":"Can M, Besirbellioglu BA, Avci IY, Beker CM, Pahsa A. Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: a prospective study. Med Sci Monit 2006; 12(4): I19-I22."},{"key":"9762_CR4436","doi-asserted-by":"crossref","unstructured":"Cindoruk M, Erkan G, Karakan T, Dursun A, Unal S. Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study. Helicobacter 2007; 12(4): 309-316.","DOI":"10.1111\/j.1523-5378.2007.00516.x"},{"key":"9762_CR4442","doi-asserted-by":"crossref","unstructured":"Cremonini F, Di Caro S, Covino M, et al. Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 2002; 97(11): 2744-2749.","DOI":"10.1111\/j.1572-0241.2002.07063.x"},{"key":"9762_CR4446","doi-asserted-by":"crossref","unstructured":"Duman DG, Bor S, Ozutemiz O, et al. Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication. Eur J Gastroenterol Hepatol 2005; 17(12): 1357-1361.","DOI":"10.1097\/00042737-200512000-00015"},{"key":"9762_CR4450","unstructured":"Ehrhardt S, Guo N, Hinz R, et al. Saccharomyces boulardii to prevent antibiotic-associated diarrhea: a randomized, double-masked, placebo-controlled trial. Open Forum Infect Dis 2016; 3(1): ofw011."},{"key":"9762_CR4454","doi-asserted-by":"crossref","unstructured":"Lewis SJ, Freedman AR. Review article: the use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease. Aliment Pharmacol Ther 1998; 12(9): 807-822.","DOI":"10.1046\/j.1365-2036.1998.00386.x"},{"key":"9762_CR4458","unstructured":"McFarland LV, Surawicz CM, Greenberg RN, et al. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am J Gastroenterol 1995; 90(3): 439-448."},{"key":"9762_CR4462","doi-asserted-by":"crossref","unstructured":"Pozzoni P, Riva A, Bellatorre AG, et al. Saccharomyces boulardii for the prevention of antibiotic- associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial. Am J Gastroenterol 2012; 107(6): 922-931.","DOI":"10.1038\/ajg.2012.56"},{"key":"9762_CR4466","doi-asserted-by":"crossref","unstructured":"Surawicz CM, Elmer GW, Speelman P, McFarland LV, Chinn J, van Belle G. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 1989; 96(4): 981-988.","DOI":"10.1016\/0016-5085(89)91613-2"},{"key":"9762_CR4470","unstructured":"Zhang DM, Xu BB, Yu L, Zheng LF, Chen LP, Wang W. A prospective control study of Saccharomyces boulardii in prevention of antibiotic-associated diarrhea in the older inpatients. Zhonghua Nei Ke Za Zhi 2017; 56(6): 398-401."},{"key":"9762_CR4474","unstructured":"Monteiro E, Fernandes JP, Vieira MR, et al. Double blind clinical trial on the use of ultra-levure in the prophylaxis of antibiotic induced gastro-intestinal and mucocutaneous disorders. Acta Med Port 1981; 3(2): 143-145."},{"key":"9762_CR4478","doi-asserted-by":"crossref","unstructured":"Arvola T, Laiho K, Torkkeli S, et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 1999; 104(5): e64.","DOI":"10.1542\/peds.104.5.e64"},{"key":"9762_CR4484","doi-asserted-by":"crossref","unstructured":"Esposito C, Roberti A, Turr\u00e0 F, et al. Frequency of antibiotic-associated diarrhea and related complications in pediatric patients who underwent hypospadias repair: a comparative study using probiotics vs placebo. Probiotics Antimicrob Proteins 2018; 10(2): 323-328.","DOI":"10.1007\/s12602-017-9324-4"},{"key":"9762_CR4303","unstructured":"King SN, Chung AM, Vidal R, Walton S, Bonafante E, Falkos S. A randomized, double-blind, placebo controlled trial to assess the efficacy of Lactobacillus GG in the prevention of antibioticassociated diarrhea in the Pediatric Intensive Care Unit (PICU). Pharmacotherapy 2010; 30(10): 457e-8e."},{"key":"9762_CR4490","doi-asserted-by":"crossref","unstructured":"Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 1999; 135(5): 564-568.","DOI":"10.1016\/S0022-3476(99)70053-3"},{"key":"9762_CR4307","unstructured":"Vaisanen L, Leskinen M, Siitonen A. Occurence of diarrhea in children receiving oral antibiotics with or without probiotic supplementation with Lactobacillus GG. Microb Ecol Health Dis 1998; 10: 199-200."},{"key":"9762_CR4496","doi-asserted-by":"crossref","unstructured":"Armuzzi A, Cremonini F, Bartolozzi F, et al. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2001; 15(2): 163-169.","DOI":"10.1046\/j.1365-2036.2001.00923.x"},{"key":"9762_CR4500","doi-asserted-by":"crossref","unstructured":"Armuzzi A, Cremonini F, Ojetti V, et al. Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Digestion 2001; 63(1): 1-7.","DOI":"10.1159\/000051865"},{"key":"9762_CR4311","doi-asserted-by":"crossref","unstructured":"Thomas MR, Litin SC, Osmon DR, Corr AP, Weaver AL, Lohse CM. Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial. Mayo Clin Proc 2001; 76(9): 883-889.","DOI":"10.1016\/S0025-6196(11)62106-X"},{"key":"9762_CR4329","doi-asserted-by":"crossref","unstructured":"Beausoleil M, Fortier N, Gu\u00e9nette S, et al. Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial. Can J Gastroenterol 2007; 21(11): 732-736.","DOI":"10.1155\/2007\/720205"},{"key":"9762_CR4333","doi-asserted-by":"crossref","unstructured":"Gao XW, Mubasher M, Fang CY, Reifer C, Miller LE. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. Am J Gastroenterol 2010; 105(7): 1636-1641.","DOI":"10.1038\/ajg.2010.11"},{"key":"9762_CR4337","unstructured":"Sampalis J, Psaradellis E, Rampakakis E. Efficacy of BIO K+ CL1285 in the reduction of antibiotic-associated diarrhea - a placebo controlled double-blind randomized, multi-center study. Arch Med Sci 2010; 6(1): 56-64."},{"key":"9762_CR4345","doi-asserted-by":"crossref","unstructured":"Hickson M, D'Souza AL, Muthu N, et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 2007; 335(7610): 80.","DOI":"10.1136\/bmj.39231.599815.55"},{"key":"9762_CR4355","doi-asserted-by":"crossref","unstructured":"Ouwehand AC, DongLian C, Weijian X, et al. Probiotics reduce symptoms of antibiotic use in a hospital setting: a randomized dose response study. Vaccine 2014; 32(4): 458-463.","DOI":"10.1016\/j.vaccine.2013.11.053"},{"key":"9762_CR4374","doi-asserted-by":"crossref","unstructured":"Lang FC. Use of a multi-species probiotic. Nutrafoods 2010; 9(2): 27-31.","DOI":"10.1007\/BF03223333"},{"key":"9762_CR4364","doi-asserted-by":"crossref","unstructured":"Koning CJ, Jonkers DM, Stobberingh EE, Mulder L, Rombouts FM, Stockbrugger RW. The effect of a multispecies probiotic on the intestinal microbiota and bowel movements in healthy volunteers taking the antibiotic amoxycillin. Am J Gastroenterol 2008; 103(1): 178-189.","DOI":"10.1111\/j.1572-0241.2007.01547.x"},{"key":"9762_CR4386","doi-asserted-by":"crossref","unstructured":"Georgieva M, Pancheva R, Rasheva N, Usheva N, Ivanova L, Koleva K. Use of the probiotic Lactobacillus reuteri DSM 17938 in the prevention of antibiotic-associated infections in hospitalized bulgarian children: a randomized, controlled trial. J IMAB 2015; 21(4): 895-900.","DOI":"10.5272\/jimab.2015214.895"},{"key":"9762_CR4390","doi-asserted-by":"crossref","unstructured":"Ko\u0142odziej M, Szajewska H. Lactobacillus reuteri DSM 17938 in the prevention of antibiotic-associated diarrhoea in children: a randomized clinical trial. Clin Microbiol Infect 2019; 25(6): 699-704.","DOI":"10.1016\/j.cmi.2018.08.017"},{"key":"9762_CR4382","doi-asserted-by":"crossref","unstructured":"Cimperman L, Bayless G, Best K, et al. A randomized, double-blind, placebo-controlled pilot study of Lactobacillus reuteri ATCC 55730 for the prevention of antibiotic-associated diarrhea in hospitalized adults. J Clin Gastroenterol 2011; 45(9): 785-789.","DOI":"10.1097\/MCG.0b013e3182166a42"},{"key":"9762_CR4287","doi-asserted-by":"crossref","unstructured":"Szajewska H, Kolodziej M. Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2015; 42(7): 793-801.","DOI":"10.1111\/apt.13344"},{"key":"9762_CR4291","doi-asserted-by":"crossref","unstructured":"Szajewska H, Mrukowicz J. Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2005; 22(5): 365-372.","DOI":"10.1111\/j.1365-2036.2005.02624.x"},{"key":"9762_CR4299","doi-asserted-by":"crossref","unstructured":"Szajewska H, Canani RB, Guarino A, et al. Probiotics for the prevention of antibiotic-associated diarrhea in children. J Pediatr Gastroenterol Nutr 2016; 62(3): 495-506.","DOI":"10.1097\/MPG.0000000000001081"},{"key":"9762_CR4321","doi-asserted-by":"crossref","unstructured":"Szajewska H, Kolodziej M. Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults. Aliment Pharmacol Ther 2015; 42(10): 1149-1157.","DOI":"10.1111\/apt.13404"},{"key":"9762_CR4368","unstructured":"WHO. Diarrhoeal disease 2017 [updated 2 May 2017]. Available from: https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/diarrhoeal-disease."}],"container-title":["MMW - Fortschritte der Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-021-9762-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15006-021-9762-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-021-9762-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T11:30:54Z","timestamp":1618227054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.springermedizin.de\/doi\/10.1007\/s15006-021-9762-5"}},"subtitle":["Systematischer Review"],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":50,"journal-issue":{"issue":"S4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["9762"],"URL":"https:\/\/doi.org\/10.1007\/s15006-021-9762-5","relation":{},"ISSN":["1438-3276","1613-3560"],"issn-type":[{"value":"1438-3276","type":"print"},{"value":"1613-3560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"29 April 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Prof. Dr. med. Martin Storr erhielt Honorare f\u00fcr Vortr\u00e4ge\/Beratung von Dr. Falk Pharma, Synformulas, Dr. Kade, Microbiotica, GE Healthcare, Medice, Salus, Klinge und HlH Biopharma. Prof. Dr. med. Andreas Stengel erhielt Honorare f\u00fcr Vortr\u00e4ge\/Beratung von a + r Berlin, Boehringer-Ingelheim, Dr. Wilmar Schwabe, Medice, Microbiotica und Takeda.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Die Arbeit wurde unterst\u00fctzt von der MEDICE Arzneimittel P\u00fctter GmbH & Co. KG, Iserlohn.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}